Cyto Study Manager

Cyto Study Manager is a comprehensive platform aimed at streamlining genotoxicity workflows by integrating data acquisition, auditing, reporting, and study management in a single, GLP-compliant system. It assists researchers in lowering costs, reducing transcription errors, and ensuring regulatory compliance with certainty.

This solution promotes efficiency, traceability, and acceleration of studies, offering robust support for preclinical research by centralizing diverse datasets from various genotoxicity studies such as comet and transgenic rodent assays. Cyto Study Manager simplifies data review, approval processes, and regulatory audits, mitigating risks associated with data mismanagement.

The platform provides extensive automation and customization, which helps minimize manual input, decrease error rates, and expedite the completion of study timelines. Through seamless integration with laboratory equipment, Cyto Study Manager supports a full suite of genotoxicity assays.

Key Benefits:

• Saves Time: It reduces manual effort through preconfigured templates and automated data capture, ensuring efficient and reproducible workflows.
• Improved Compliance: With built-in audit trails and electronic signature support, it ensures strong data integrity aligned with GLP and 21 CFR Part 11 standards.
• Enhanced Customization: The platform can be tailored for in vivo or in vitro assays and varied experimental designs, accommodating diverse data collection stages and endpoints.
• Greater Study Integrity: Coded sample management diminishes scorer bias, while centralized data handling assures objectivity and consistency.

Core Features/Modules:

• Ames Assay In Vitro: Integrates the Sorcerer Colony Counter for automatic plate counting and observation input.
• Comet Assay In Vitro and In Vivo: Supports real-time scoring or imports from third-party tools for comprehensive analysis.
• Micronucleus In Vitro and In Vivo: Offers flexible data input methods, including manual entry and data imports from automation platforms.
• Chromosome Aberrations In Vitro and In Vivo: Enables direct data entry in place of paper-based methods.
• Neutral Red Uptake In Vitro: Provides configurable layouts compliant with OECD and Health Canada standards to streamline setup.
• Transgenic Rodent (MutaMouse and Big Blue): Facilitates tracking of DNA events with automatic flagging of out-of-range values.